CY1115171T1 - Ιατρικο φαρμακο - Google Patents
Ιατρικο φαρμακοInfo
- Publication number
- CY1115171T1 CY1115171T1 CY20141100316T CY141100316T CY1115171T1 CY 1115171 T1 CY1115171 T1 CY 1115171T1 CY 20141100316 T CY20141100316 T CY 20141100316T CY 141100316 T CY141100316 T CY 141100316T CY 1115171 T1 CY1115171 T1 CY 1115171T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- formula
- hydrogen atom
- atoms
- present
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ένα αντικείμενο της παρούσας εφεύρεσης είναι να παρέχει ιατρικό φάρμακο πολύ βελτιωμένο στη δραστικότητα κατά του όγκου και εξαιρετικής ασφάλειας. Σύμφωνα προς την παρούσα εφεύρεση, παρέχεται ένα ιατρικό φάρμακο που περιέχει μία ένωση που αντιπροσωπεύεται από τον ακόλουθο γενικό τύπο (1) ή άλας αυτής ως δραστικό συστατικό: [Τύπος 1] όπου το Χ1, αντιπροσωπεύει άτομο αζώτου ή μια ομάδα -CH =, το R1 αντιπροσωπεύει μια ομάδα -ZR6, όπου το Ζ αντιπροσωπεύει μία ομάδα -CO-, ομάδα -CH(OH)- ή τις παρόμοιες, το R6 αντιπροσωπεύει 5-μελή έως 15-μελή μονοκυκλική, δικυκλική ή τρικυκλική κορεσμένη ή ακόρεστη ετεροκυκλική ομάδα έχουσα 1 έως 4 άτομα αζώτου, άτομα οξυγόνου ή άτομα θείου, το R2 αντιπροσωπεύει άτομο υδρογόνου ή άτομο αλογόνου, το Υ αντιπροσωπεύει μία ομάδα -Ο-, μία ομάδα -CO-, μία ομάδα -CH(OH)- ή κατώτερη αλκυλένο ομάδα και το Α αντιπροσωπεύει [Τύπος 2] όπου το R3 αντιπροσωπεύει άτομο υδρογόνου, κατώτερη αλκόξυ ομάδα ή τις παρόμοιες, το p αντιπροσωπεύει 1 ή 2, το R4 αντιπροσωπεύει ιμιδαζολύλ κατώτερη αλκύλ ομάδα ή τις παρόμοιες.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005351255 | 2005-12-05 | ||
| EP06834365.6A EP1957073B1 (en) | 2005-12-05 | 2006-12-04 | Medicinal drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115171T1 true CY1115171T1 (el) | 2016-12-14 |
Family
ID=38051953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100316T CY1115171T1 (el) | 2005-12-05 | 2014-05-05 | Ιατρικο φαρμακο |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8236826B2 (el) |
| EP (1) | EP1957073B1 (el) |
| KR (1) | KR101157004B1 (el) |
| CN (1) | CN101321529B (el) |
| AR (1) | AR056885A1 (el) |
| AU (1) | AU2006323700B2 (el) |
| BR (1) | BRPI0619349A2 (el) |
| CA (1) | CA2630468C (el) |
| CY (1) | CY1115171T1 (el) |
| DK (1) | DK1957073T3 (el) |
| ES (1) | ES2463450T3 (el) |
| IL (1) | IL191544A0 (el) |
| MY (1) | MY146514A (el) |
| NO (1) | NO20081934L (el) |
| PL (1) | PL1957073T3 (el) |
| PT (1) | PT1957073E (el) |
| RU (1) | RU2444362C2 (el) |
| SI (1) | SI1957073T1 (el) |
| TW (1) | TWI332838B (el) |
| WO (1) | WO2007066784A2 (el) |
| ZA (1) | ZA200804445B (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100927563B1 (ko) | 2004-08-06 | 2009-11-23 | 오쓰까 세이야꾸 가부시키가이샤 | 방향족 화합물 |
| UA95978C2 (ru) * | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| CN101597278B (zh) | 2008-06-04 | 2013-04-17 | 中国中化股份有限公司 | 酰胺类化合物及其制备与应用 |
| JP2012509879A (ja) | 2008-11-21 | 2012-04-26 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | アダマンチルベンズアミド化合物 |
| JP5487202B2 (ja) | 2009-04-20 | 2014-05-07 | 田辺三菱製薬株式会社 | 新規甲状腺ホルモンβ受容体作動薬 |
| JP5758395B2 (ja) | 2009-10-15 | 2015-08-05 | ザ チルドレンズ メディカル センター コーポレイション | 疼痛を治療するためのセピアプテリンレダクターゼ阻害薬 |
| PL2528897T3 (pl) * | 2010-01-29 | 2015-03-31 | Otsuka Pharma Co Ltd | Di-podstawione pochodne pirydyny jako leki przeciwnowotworowe |
| WO2012015715A1 (en) | 2010-07-27 | 2012-02-02 | High Point Pharmaceuticals, Llc | Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators |
| PL2624833T3 (pl) | 2010-10-04 | 2015-05-29 | Otsuka Pharma Co Ltd | Pochodne 4-(metyloaminofenoksy)pirydyn-3-ylo-benzamidu do leczenia nowotworów |
| WO2012090177A2 (en) * | 2010-12-30 | 2012-07-05 | Lupin Limited | Cannabinoid receptor modulators |
| IN2014MN00226A (el) * | 2011-07-05 | 2015-09-25 | Lupin Ltd | |
| TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| US9376376B2 (en) | 2012-03-14 | 2016-06-28 | Sinochem Corporation | Substitute diphenylamine compounds use thereof as antitumor agents |
| JP6066806B2 (ja) * | 2012-04-03 | 2017-01-25 | 大塚製薬株式会社 | 医薬 |
| BR122017003181A2 (pt) | 2013-02-19 | 2019-09-10 | Ono Pharmaceutical Co | composto inibidor de trk, composição farmacêutica e medicamento compreendendo dito composto e seu uso para profilaxia e/ou terapia de doença relacionada à trk e/ou para inibir trk |
| PE20160434A1 (es) * | 2013-09-09 | 2016-05-25 | Peloton Therapeutics Inc | Eteres de arilo y sus usos |
| WO2015179414A1 (en) * | 2014-05-19 | 2015-11-26 | Merial, Inc. | Anthelmintic compounds |
| TW201617314A (zh) * | 2014-09-10 | 2016-05-16 | 第一三共股份有限公司 | 羧酸衍生物 |
| CN107098884A (zh) * | 2016-02-19 | 2017-08-29 | 中国科学院上海药物研究所 | 一类取代的氨基吡啶类化合物及其制备和用途 |
| WO2020059841A1 (ja) * | 2018-09-21 | 2020-03-26 | 国立大学法人 長崎大学 | プリオン病治療薬 |
| IL314626A (en) * | 2022-02-28 | 2024-09-01 | Sironax Ltd | Preparation of RIP1 modulators and their uses |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE629102A (el) * | 1961-03-29 | |||
| NL7111711A (el) | 1970-09-17 | 1972-03-21 | ||
| US3715375A (en) * | 1970-09-17 | 1973-02-06 | Merck & Co Inc | New diphenyl sulfones |
| GB1494117A (en) | 1974-11-02 | 1977-12-07 | Bayer Ag | Process for the preparation of acid amides |
| DE2707659A1 (de) * | 1977-02-23 | 1978-08-24 | Bayer Ag | Selbstvernetzbare polyurethane |
| DE2707660C2 (de) * | 1977-02-23 | 1985-12-19 | Bayer Ag, 5090 Leverkusen | Abspalter- und Diolrest enthaltende Diisocyanat-Addukte, ihre Herstellung und Verwendung |
| DE2812252A1 (de) * | 1978-03-21 | 1979-10-04 | Bayer Ag | 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel |
| US4978672A (en) * | 1986-03-07 | 1990-12-18 | Ciba-Geigy Corporation | Alpha-heterocyclc substituted tolunitriles |
| EP0500495A3 (en) * | 1991-02-21 | 1993-04-07 | Ciba-Geigy Ag | Thermosetting composition |
| DE69314718T2 (de) * | 1992-07-21 | 1998-02-26 | Ciba Geigy Ag | Oxamidsäure-Derivate als hypocholesterämische Mittel |
| AU7006094A (en) | 1993-06-30 | 1995-01-24 | Wellcome Foundation Limited, The | Anti-atherosclerotic diaryl compounds |
| JPH11511121A (ja) | 1995-06-07 | 1999-09-28 | インスティテュート オブ マテリア メディカ | カルコンレチノイドおよびその使用方法 |
| US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
| EP1060175B1 (de) | 1998-02-06 | 2004-11-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| EP1060171A2 (de) | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| AR015733A1 (es) * | 1998-03-25 | 2001-05-16 | Otsuka Pharma Co Ltd | DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. |
| TWI245035B (en) | 1998-06-26 | 2005-12-11 | Ono Pharmaceutical Co | Amino acid derivatives and a pharmaceutical composition comprising the derivatives |
| EP1101755B1 (en) | 1998-07-24 | 2004-10-06 | Teijin Limited | Anthranilic acid derivatives |
| EP1140840B1 (en) * | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US20020065296A1 (en) * | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| WO2000046203A2 (en) | 1999-02-04 | 2000-08-10 | Millennium Pharmaceuticals, Inc. | G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| CO5160290A1 (es) | 1999-03-29 | 2002-05-30 | Novartis Ag | Derivados de acido fenoxifeniloxamico sustituido . |
| US6159694A (en) * | 1999-04-08 | 2000-12-12 | Isis Pharmaceuticals Inc. | Antisense modulation of stat3 expression |
| JP4609691B2 (ja) | 1999-07-01 | 2011-01-12 | 味の素株式会社 | 複素環化合物及びその医薬用途 |
| JP2001089412A (ja) | 1999-09-22 | 2001-04-03 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体またはその医薬的に許容される塩 |
| JP2001089450A (ja) | 1999-09-22 | 2001-04-03 | Otsuka Pharmaceut Co Ltd | ピリジン誘導体含有医薬製剤 |
| AU3408901A (en) * | 2000-02-15 | 2001-08-27 | Teijin Ltd | Cancer remedy comprising anthranilic acid derivative as active ingredient |
| IL152830A0 (en) | 2000-05-22 | 2003-06-24 | Aventis Pharma Inc | Arylmethylamine derivatives for use as tryptase inhibitors |
| GB0015205D0 (en) | 2000-06-21 | 2000-08-09 | Karobio Ab | Bioisosteric thyroid receptor ligands and method |
| JP2004506735A (ja) | 2000-08-18 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用キヌクリジン置換アリール化合物 |
| WO2002026191A2 (en) | 2000-09-28 | 2002-04-04 | Nanocyte Inc. | Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| AU2002223626A1 (en) | 2000-10-20 | 2002-04-29 | Novartis Ag | Combinations of a thyromimetic compound and a statin |
| EP1211235A3 (en) | 2000-11-30 | 2004-01-02 | JFE Chemical Corporation | Preparation process of 4,4'-Dicarboxydiphenyl ethers or derivatives thereof |
| JP2004269356A (ja) | 2000-12-27 | 2004-09-30 | Ajinomoto Co Inc | 創傷部癒着防止剤 |
| GB2374009A (en) | 2001-02-12 | 2002-10-09 | Novartis Ag | Method of treating hair loss |
| YU94103A (sh) | 2001-06-20 | 2006-03-03 | Pfizer Products Inc. | Novi derivati sulfonske kiseline |
| JP2005504059A (ja) | 2001-08-24 | 2005-02-10 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン |
| KR20040047941A (ko) | 2001-10-22 | 2004-06-05 | 화이자 프로덕츠 인크. | Ccr1 수용체 길항제 활성을 갖는 피페라진 유도체 |
| WO2003035602A1 (en) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Lipid modulators |
| EP1480977A2 (en) | 2002-02-15 | 2004-12-01 | PHARMACIA & UPJOHN COMPANY | Substituted aryl compounds for treatment of disease |
| FR2836917B1 (fr) | 2002-03-11 | 2006-02-24 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif |
| JP2004035475A (ja) | 2002-07-03 | 2004-02-05 | Ajinomoto Co Inc | TGFβ作用抑制剤 |
| TW201018661A (en) * | 2003-03-14 | 2010-05-16 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
| WO2005007621A2 (en) | 2003-05-30 | 2005-01-27 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| ZA200510137B (en) * | 2003-07-24 | 2007-04-25 | Leo Pharma As | Novel aminobenzophenone compounds |
| KR100927563B1 (ko) * | 2004-08-06 | 2009-11-23 | 오쓰까 세이야꾸 가부시키가이샤 | 방향족 화합물 |
| UA95978C2 (ru) * | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| TWI440638B (zh) * | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
-
2006
- 2006-12-04 WO PCT/JP2006/324610 patent/WO2007066784A2/en not_active Ceased
- 2006-12-04 KR KR1020087013451A patent/KR101157004B1/ko not_active Expired - Fee Related
- 2006-12-04 PL PL06834365T patent/PL1957073T3/pl unknown
- 2006-12-04 RU RU2008127325/15A patent/RU2444362C2/ru not_active IP Right Cessation
- 2006-12-04 MY MYPI20081824A patent/MY146514A/en unknown
- 2006-12-04 CN CN2006800454525A patent/CN101321529B/zh not_active Expired - Fee Related
- 2006-12-04 AU AU2006323700A patent/AU2006323700B2/en not_active Ceased
- 2006-12-04 PT PT68343656T patent/PT1957073E/pt unknown
- 2006-12-04 SI SI200631802T patent/SI1957073T1/sl unknown
- 2006-12-04 CA CA2630468A patent/CA2630468C/en not_active Expired - Fee Related
- 2006-12-04 ES ES06834365.6T patent/ES2463450T3/es active Active
- 2006-12-04 US US12/095,930 patent/US8236826B2/en not_active Expired - Fee Related
- 2006-12-04 ZA ZA200804445A patent/ZA200804445B/xx unknown
- 2006-12-04 EP EP06834365.6A patent/EP1957073B1/en not_active Not-in-force
- 2006-12-04 BR BRPI0619349-8A patent/BRPI0619349A2/pt not_active IP Right Cessation
- 2006-12-04 DK DK06834365.6T patent/DK1957073T3/da active
- 2006-12-05 TW TW095145184A patent/TWI332838B/zh active
- 2006-12-05 AR ARP060105371A patent/AR056885A1/es unknown
-
2008
- 2008-04-23 NO NO20081934A patent/NO20081934L/no not_active Application Discontinuation
- 2008-05-19 IL IL191544A patent/IL191544A0/en not_active IP Right Cessation
-
2014
- 2014-05-05 CY CY20141100316T patent/CY1115171T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200804445B (en) | 2009-11-25 |
| IL191544A0 (en) | 2008-12-29 |
| WO2007066784A2 (en) | 2007-06-14 |
| AR056885A1 (es) | 2007-10-31 |
| EP1957073A2 (en) | 2008-08-20 |
| KR20080070054A (ko) | 2008-07-29 |
| RU2008127325A (ru) | 2010-01-20 |
| WO2007066784A3 (en) | 2007-10-25 |
| CN101321529B (zh) | 2012-09-05 |
| CN101321529A (zh) | 2008-12-10 |
| MY146514A (en) | 2012-08-15 |
| US8236826B2 (en) | 2012-08-07 |
| CA2630468C (en) | 2015-01-20 |
| EP1957073B1 (en) | 2014-04-23 |
| NO20081934L (no) | 2008-08-13 |
| HK1123219A1 (en) | 2009-06-12 |
| TW200800200A (en) | 2008-01-01 |
| RU2444362C2 (ru) | 2012-03-10 |
| DK1957073T3 (da) | 2014-05-12 |
| PT1957073E (pt) | 2014-05-12 |
| SI1957073T1 (sl) | 2014-08-29 |
| US20100004438A1 (en) | 2010-01-07 |
| ES2463450T3 (es) | 2014-05-28 |
| AU2006323700A1 (en) | 2007-06-14 |
| BRPI0619349A2 (pt) | 2011-11-08 |
| KR101157004B1 (ko) | 2012-07-09 |
| AU2006323700B2 (en) | 2011-02-17 |
| TWI332838B (en) | 2010-11-11 |
| CA2630468A1 (en) | 2007-06-14 |
| PL1957073T3 (pl) | 2014-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1115171T1 (el) | Ιατρικο φαρμακο | |
| CY1119882T1 (el) | Παραγωγο πυριμιδινης ως αναστολεας ρι3κ και χρηση αυτου | |
| MX2024001824A (es) | Compuestos heterociclicos y metodos de uso. | |
| GB0005357D0 (en) | Compounds | |
| CY1111493T1 (el) | Παραγωγα πυραζολιου ως τροποποιητες πρωτεϊνοκινασης | |
| DE60103136D1 (de) | Imidazol derivate als raf kinase inhibitoren | |
| PH12021551257A1 (en) | Cyclic pantetheine derivatives and uses thereof | |
| CY1111069T1 (el) | Παραγωγα διυδροπυραζολοπυριμιδινονης | |
| IL150481A0 (en) | 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors | |
| CY1115548T1 (el) | Ενωση κυκλικης αμινης και παραγων ελεγχου παρασιτων | |
| PE20040189A1 (es) | Pirimidina y piridina biciclicos como inhibidores de p38 quinasa | |
| WO2004018475A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents | |
| ATE403653T1 (de) | Pyridin-substituierte furanderivate als raf- kinase inhibitoren | |
| WO2006136837A3 (en) | Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| EA200701780A1 (ru) | Противоопухолевое средство | |
| JP2007514639A5 (el) | ||
| MY137964A (en) | Benzofuran derivative | |
| EA200971003A1 (ru) | Бициклическое соединение и его фармацевтическое применение | |
| ZA200703275B (en) | 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinollnecarbonitriles for the treatment of ischemic Injury | |
| ATE483689T1 (de) | Pyrazolderivate als modulatoren von proteinkinase | |
| MX387656B (es) | Compuesto de pirrolo[2,3-d]pirimidina o sal del mismo. | |
| MY144464A (en) | Pyrazole derivatives as protien kinase modulators | |
| EP4552638A3 (de) | Tofa-analoga, zubereitungen zur sebumreduktion mit einem gehalt an solchen analoga und die kosmetische und/oder therapeutische verwendung solcher analoga als wirksames prinzip zur sebumreduktion oder -verhinderung | |
| ATE461702T1 (de) | Krebsmittel |